International Conference on Cell Therapy for Cardiovascular Disease Set for Jan. 13-16
November 10, 2008 - The Fifth International Conference on Cell Therapy for Cardiovascular Disease (IC3D) is a three-day program dedicated to cell-based therapies for cardiovascular repair and regeneration at the New York Academy of Medicine in New York City.
Abstracts are being requested from basic, translational, and clinical scientists who are interested in having data presented at IC3D. The deadline in Dec. 1. Content suitable for presentation at this meeting includes, but is not limited to, development of adult and embryonic stem cell lines; molecular signaling and cellular responses; models of acute and chronic myocardial injury; methods for application of stem cell products; preclinical and clinical studies of stem cell-based repair; engineered tissue including in vitro and in vivo studies; and imaging and other assessment methods.
Abstract submissions will be peer reviewed. Those accepted will be presented as posters at times that coincide with the themes of the IC3D program as they change each day.
For more information: www.crf.org/Cell_Therapy
More like this
- CRF to Hold CVD Cell Therapy Conference
- Serbian Center Treats First Patient With Heart Failure Stem Cell Therapy
- NeoStem Provides Update on Amorcyte Stem Cell Treatment Clinical Progress
- University of Maryland Study Suggests Neonatal Cardiac Stem Cells May Help Mend Children's Broken Hearts
- University of Miami’s Stem Cell Institute Awarded $10 Million